Michael Combs

Dec 13, 2024 | riskandinsurance.com | Michael Combs

Topics: Artificial Intelligence | Risk Insider | Technology | Workers' Comp | Workers' Comp Forum 2024 was a year of steady growth for the risk management profession, largely attributed to the implementation of generative AI (GenAI). This technology, amongst others, continues to progress through the innovation cycle as demand increases and organizations look for ways to cut costs and improve overall operational efficiency.

May 23, 2024 | jhltonline.org | Michael Combs |Elizabeth A. Belloli |Kevin Flaherty

KEYWORDSchronic lung allograft dysfunctionCLADpirfenidoneantifibrotic therapyclinical trialGet full text accessLog in, subscribe or purchase for full access. References1. Singer, J.P. ∙ Singer, L.G.Quality of life in lung transplantationSemin Respir Crit Care Med. 2013; 34:421-4302. Titman, A. ∙ Rogers, C.A. ∙ Bonser, R.S. ... Disease-specific survival benefit of lung transplantation in adults: a national cohort studyAm J Transplant. 2009; 9:1640-16493. Ofek, E. ∙ Sato, M. ∙ Saito, T. ...

Apr 29, 2024 | riskandinsurance.com | Michael Combs

Topics: Artificial Intelligence | Risk Insider | Technology | Workers' Comp | Workers' Comp Forum Understanding and preparing for the impact of our aging population on the workforce can benefit all industries, including insurance. As 11,000 Americans turn 65 every day, over 4.1 million will retire in 2024, setting a record. However, the industry can mitigate the impact of the looming resource transformation by leveraging the power of technology.

Mar 28, 2024 | jhltonline.org | Janelle Pugashetti |John Kim |Michael Combs

Lung transplantation remains the sole curative option for patients with idiopathic pulmonary fibrosis (IPF), but donor organs remain scarce, and many eligible patients die prior to transplant. Tools to optimize the timing of transplant referral are urgently needed.

Sep 10, 2023 | thelancet.com | Michael Combs

1 Verleden GM Glanville AR Lease ED et al. Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment—a consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant.